Viewing StudyNCT00123877



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00123877
Status: TERMINATED
Last Update Posted: 2007-01-09
First Post: 2005-07-23

Brief Title: Study of GPX-100 in the Treatment of Metastatic Breast Cancer
Sponsor: Gem Pharmaceuticals
Organization: Gem Pharmaceuticals

Organization Data

Organization: Gem Pharmaceuticals
Class: INDUSTRY
Study ID: GPX-100-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Gem Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators